PL370292A1 - Preparaty - Google Patents

Preparaty

Info

Publication number
PL370292A1
PL370292A1 PL03370292A PL37029203A PL370292A1 PL 370292 A1 PL370292 A1 PL 370292A1 PL 03370292 A PL03370292 A PL 03370292A PL 37029203 A PL37029203 A PL 37029203A PL 370292 A1 PL370292 A1 PL 370292A1
Authority
PL
Poland
Prior art keywords
oral administration
active compounds
formulations
pharmaceutical compositions
relates
Prior art date
Application number
PL03370292A
Other languages
English (en)
Other versions
PL212123B1 (pl
Inventor
Domenico Fanara
Monique Berwaer
Anthony Guichaux
Michel Deleers
Original Assignee
Ucb Farchim S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Farchim S.A. filed Critical Ucb Farchim S.A.
Publication of PL370292A1 publication Critical patent/PL370292A1/pl
Publication of PL212123B1 publication Critical patent/PL212123B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL370292A 2002-01-15 2003-01-14 Doustna kompozycja farmaceutyczna PL212123B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02000871 2002-01-15

Publications (2)

Publication Number Publication Date
PL370292A1 true PL370292A1 (pl) 2005-05-16
PL212123B1 PL212123B1 (pl) 2012-08-31

Family

ID=8185261

Family Applications (1)

Application Number Title Priority Date Filing Date
PL370292A PL212123B1 (pl) 2002-01-15 2003-01-14 Doustna kompozycja farmaceutyczna

Country Status (19)

Country Link
US (3) US20050038039A1 (pl)
EP (1) EP1467715B1 (pl)
JP (4) JP4724367B2 (pl)
KR (1) KR101005648B1 (pl)
CN (2) CN101632642B (pl)
AT (1) ATE486587T1 (pl)
AU (3) AU2003201161B2 (pl)
BR (1) BR0306870A (pl)
CA (1) CA2472396A1 (pl)
CO (1) CO5590918A2 (pl)
DE (1) DE60334773D1 (pl)
ES (1) ES2354688T3 (pl)
MX (1) MXPA04006775A (pl)
NO (1) NO333936B1 (pl)
NZ (1) NZ534039A (pl)
PL (1) PL212123B1 (pl)
RU (1) RU2004123612A (pl)
WO (1) WO2003059328A1 (pl)
ZA (1) ZA200404796B (pl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100335041C (zh) * 2002-04-04 2007-09-05 辉瑞产品公司 美味咀嚼片剂
PL1729813T3 (pl) * 2004-04-01 2011-09-30 Pf Medicament Kompleksy inkluzyjne zawierające piroksykam, cyklodekstrynę i argininę
ES2385832T3 (es) * 2004-05-21 2012-08-01 Accu-Break Technologies, Inc. Comprimidos farmacéuticos que presentan un segmento relativamente inactivo
US7622137B2 (en) * 2004-05-21 2009-11-24 Accu-Break Technologies, Inc. Dosage forms contained within a capsule or sachet
US7838031B2 (en) 2004-05-21 2010-11-23 Lawrence Solomon Method of administering a partial dose using a segmented pharmaceutical tablet
US7318935B2 (en) * 2004-05-21 2008-01-15 Accu-Break Technologies, Inc. Pharmaceutical tablets with active and inactive segments
US7713547B2 (en) 2004-05-21 2010-05-11 Accu-Break Pharmaceuticals, Inc. Method of administering a partial dose of a segmented pharmaceutical tablet
US7329418B2 (en) * 2004-05-21 2008-02-12 Accu Break Technologies, Inc. Pharmaceutical tablets having height greater than width
US7780985B2 (en) * 2005-07-12 2010-08-24 Accu-Break Technologies, Inc. Tablets having a printed separation mark to guide breaking
CA2574602A1 (en) * 2004-07-22 2006-02-02 Pfizer Products Inc. Taste masking formulation comprising the drug in a dissolution-retarded form and/or cyclodextrin in a dissolution-enhanced form
US20060083786A1 (en) * 2004-07-29 2006-04-20 Glenmark Pharmaceuticals Limited Taste masking pharmaceutical composition containing levocetirizine
KR100714616B1 (ko) * 2005-06-23 2007-05-07 삼성전기주식회사 지수 함수 발생기 및 이를 이용한 가변 이득 증폭기
US20070086974A1 (en) * 2005-10-06 2007-04-19 Gawande Rahul S Cetirizine compositions
WO2007058660A1 (en) * 2005-11-18 2007-05-24 Accu-Break Technologies, Inc. Segmented pharmaceutical dosage forms
US20070237815A1 (en) * 2006-04-06 2007-10-11 Lawrence Solomon Dosage forms and methods comprising amlodipine and chlorthalidone
US20090269393A1 (en) * 2006-06-12 2009-10-29 Jubliant Organosys Limited Chewable Bilayer Tablet Formulation
EP2049089A4 (en) * 2006-08-08 2012-07-04 Accu Break Technologies Inc PHARMACEUTICAL TABLETS WITH SEVERAL ACTIVE SEGMENTS
CA2671092A1 (en) * 2006-11-30 2008-06-05 Accu-Break Technologies, Inc. Divisible osmotic dosage forms and methods of use
US20090004231A1 (en) 2007-06-30 2009-01-01 Popp Shane M Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring
US20100189768A1 (en) * 2007-07-11 2010-07-29 Fertin Pharma A/S Compressed chewing gum tablet comprising taste-masking agent
US20100260818A1 (en) * 2007-07-11 2010-10-14 Fertin Pharma A/S Stable medicated chewing gum comprising cyclodextrin inclusion complex
CN102046021A (zh) * 2008-05-26 2011-05-04 费尔廷制药公司 膜包衣压缩口香糖
EP2344137B1 (en) 2008-09-05 2015-12-02 Johnson & Johnson Consumer Inc. Method for making cetirizine tablets
WO2010107404A1 (en) 2009-03-16 2010-09-23 Mahmut Bilgic Stable pharmaceutical combinations
WO2011110939A2 (en) 2010-03-11 2011-09-15 Rubicon Research Private Limited Pharmaceutical compositions of substituted benzhydrylpiperazines
WO2011146032A2 (en) * 2010-05-18 2011-11-24 Mahmut Bilgic Effervescent formulations
CN106102715A (zh) * 2014-03-27 2016-11-09 Ucb法奇姆股份有限公司 包含左西替利嗪的药物组合物
JP2016094364A (ja) * 2014-11-14 2016-05-26 ニプロ株式会社 安定化および苦味抑制された口腔内崩壊製剤
JP7049610B2 (ja) * 2018-05-21 2022-04-07 高田製薬株式会社 レボセチリジン固形製剤
AU2021217209A1 (en) 2020-02-03 2022-09-29 Kenvue Brands Llc A single layer chewable tablet comprising cetirizine
US20230366038A1 (en) * 2022-05-16 2023-11-16 Bioo Scientific Corporation Compositions and methods relating to loop mediated isothermal amplification (lamp)

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4238510A (en) * 1979-02-21 1980-12-09 Life Savers, Inc. Sugarless coating for chewing gum and confections and method
US4260596A (en) * 1979-08-13 1981-04-07 Bristol-Myers Company Edible unit dosage form consisting of outer mannitol shell and inner liquid or gel center and method for manufacturing the same
FR2647343B1 (fr) 1989-05-24 1994-05-06 Rhone Poulenc Sante Nouvelle forme pharmaceutique poreuse et sa preparation
US5460825A (en) * 1990-05-23 1995-10-24 Mcneil-Ppc, Inc. Taste mask coatings for preparing chewable pharmaceutical tablets
NZ243667A (en) * 1991-08-02 1995-02-24 Kurihara Yoshie Chewing gum containing coated curculin derivative or fruit containing curculin
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
US5380530A (en) * 1992-12-29 1995-01-10 Whitehill Oral Technologies Oral care composition coated gum
CA2128820A1 (en) * 1993-07-27 1995-01-28 Walter G. Gowan, Jr. Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
IT1274034B (it) * 1994-07-26 1997-07-14 Applied Pharma Res Composizioni farmaceutiche a base di gomma da masticare e procedimento per la loro preparazione
US5866179A (en) * 1996-05-03 1999-02-02 Avant-Garde Technologies & Products S.A. Medicated chewing gum and a process for preparation thereof
EP0811374A1 (en) * 1996-05-29 1997-12-10 Pfizer Inc. Combination dosage form comprising cetirizine and pseudoephedrine
US6172095B1 (en) * 1996-11-25 2001-01-09 The Procter & Gamble Company Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
WO2000035298A1 (en) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Chewing gum containing medicament active agents
BE1011251A3 (fr) * 1997-07-03 1999-06-01 Ucb Sa Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine.
ATE288742T1 (de) 1997-07-10 2005-02-15 Gergely Dr & Co Lösliche, gummihaltige, dragierte kautablette
DE19814256A1 (de) 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
US6319513B1 (en) * 1998-08-24 2001-11-20 The Procter & Gamble Company Oral liquid mucoadhesive compounds
US6627234B1 (en) * 1998-12-15 2003-09-30 Wm. Wrigley Jr. Company Method of producing active agent coated chewing gum products
AU2001281749A1 (en) 2000-08-14 2002-02-25 Fertin Pharma A/S Method for preparation of chewing gum with customer acceptable taste
WO2002049607A2 (en) * 2000-12-20 2002-06-27 Firmenich Sa Flavoured oral drug delivery system
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
IL159287A0 (en) * 2001-06-28 2004-06-01 Ucb Farchim Sa Tablet comprising cetirizine and pseudoephedrine
CN100335041C (zh) * 2002-04-04 2007-09-05 辉瑞产品公司 美味咀嚼片剂

Also Published As

Publication number Publication date
JP2005518405A (ja) 2005-06-23
NO333936B1 (no) 2013-10-28
JP4724367B2 (ja) 2011-07-13
AU2008202280A1 (en) 2008-06-12
JP5467685B2 (ja) 2014-04-09
EP1467715B1 (en) 2010-11-03
AU2009203044B2 (en) 2010-06-17
MXPA04006775A (es) 2004-11-10
NO20043367L (no) 2004-08-13
US20090047344A1 (en) 2009-02-19
AU2008202280B2 (en) 2009-05-21
BR0306870A (pt) 2004-11-03
JP2010120963A (ja) 2010-06-03
ATE486587T1 (de) 2010-11-15
JP5623447B2 (ja) 2014-11-12
CN100455287C (zh) 2009-01-28
CN101632642B (zh) 2011-06-08
CA2472396A1 (en) 2003-07-24
RU2004123612A (ru) 2005-04-20
CN101632642A (zh) 2010-01-27
DE60334773D1 (de) 2010-12-16
NZ534039A (en) 2006-08-31
CN1615124A (zh) 2005-05-11
PL212123B1 (pl) 2012-08-31
JP2014024866A (ja) 2014-02-06
AU2003201161B2 (en) 2008-02-28
AU2009203044A1 (en) 2009-08-13
KR20040075075A (ko) 2004-08-26
EP1467715A1 (en) 2004-10-20
US20050038039A1 (en) 2005-02-17
WO2003059328A1 (en) 2003-07-24
CO5590918A2 (es) 2005-12-30
AU2003201161A1 (en) 2003-07-30
ZA200404796B (en) 2005-06-29
ES2354688T3 (es) 2011-03-17
HK1076605A1 (zh) 2006-01-20
US20120010218A1 (en) 2012-01-12
JP2012121917A (ja) 2012-06-28
US8946229B2 (en) 2015-02-03
KR101005648B1 (ko) 2011-01-05

Similar Documents

Publication Publication Date Title
PL370292A1 (pl) Preparaty
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
SG147450A1 (en) Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
PL369108A1 (pl) Inhibitory dehydrogenazy 17 beta-hydroksysteroidowej typu 3 do leczenia chorób zależnych od androgenu
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
EE05103B1 (et) Famatseutilised kompositsioonid, mis sisaldavad asetidiini derivaate, asetidiini derivaadid ja nende valmistamise meetodid
NZ527867A (en) Oral pharmaceutical composition of cefpodoxime proxetil
MXPA05002942A (es) Forma de dosificacion oral de liberacion modificada.
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
PA8580601A1 (es) Composicion farmaceutica de altas dosis
TW200509992A (en) Dosage form containing pantoprazole as active ingredient
SG144140A1 (en) Emulsifying systems containing azetidine derivatives
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
MXPA06000636A (es) Formulaciones semi-solidas para la administracion oral de taxoides.
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение
SG144141A1 (en) Semi-solid systems containing azetidine derivatives
WO2003086412A3 (fr) Derives poly-phosphonates pour compositions dentifrices
MD20040296A (ro) Compoziţie farmaceutică, conţinând oxcarbazepină cu eliberare prelungită a ingredientului activ
WO2001095890A3 (en) Oral pharmaceutical compositions containing terbinafine
TNSN06299A1 (en) Oral matrix formulations comprising licarbazepine

Legal Events

Date Code Title Description
RECP Rectifications of patent specification